|
CN103565788A
|
|
Pharmaceutical composition for treating depression and preparation method thereof
|
|
CN103565750A
|
|
Racecadotril particle as well as preparation method thereof
|
|
CN103214463A
|
|
Novel preparation method of sertindole
|
|
CN102836136A
|
|
Indiplon orally disintegrating tablet and preparation method thereof
|
|
CN102993055A
|
|
Polymorphic substance of guanfacine hydrochloride and preparation method thereof
|
|
CN102838520A
|
|
Amisulpride preparation method
|
|
CN102600131A
|
|
Medicine composition containing ezetimibe and simvastatin and preparation method of medicine composition
|
|
CN102579393A
|
|
Solid composition for improving content uniformity and dissolution rate of imidafenacin
|
|
CN102579386A
|
|
Stable oxiracetam preparation
|
|
CN102670602A
|
|
Solid preparation containing amlodipine and valsartan
|
|
CN102349882A
|
|
Medicinal composition containing trandolapril and preparation process thereof
|
|
CN102718709A
|
|
Novel method for preparing amonafide
|
|
CN102718749A
|
|
Preparation method of antitumor drug Nuonatini
|
|
CN102525968A
|
|
Repaglinide orally disintegrating tablet and preparation method thereof
|
|
CN102526061A
|
|
Medicinal composition and preparation method thereof
|
|
CN102558171A
|
|
Preparation method of intermediate of olprinone hydrochloride
|
|
CN101836974A
|
|
Rivastigmine-hydrogentartrate-containing pharmaceutical composition and preparation method
|
|
CN101824009A
|
|
Simple preparation method for posaconazole and piperazine intermediate thereof
|
|
CN101836982A
|
|
Medicinal composition for curing hypertension
|
|
CN102115455A
|
|
Method for preparing psilocine key intermediate
|
